Zivo Bioscience Stock Analysis


USD 2.80  0.12  4.11%   

The big decline in price over the last few months for Zivo Biosciencemay raise some interest from institutional investors as it is trading at a share price of 2.80 on 46,233 in trading volume. The company management teams failed to add value to investors and position the company supply of money to exploit market volatility in August. However, diversifying your holdings with Zivo Bioscience or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 3.87. The above-average risk is mostly attributed to market volatility and speculations regarding some of the upcoming earning calls from Zivo Bioscience partners.
Check out Your Current Watchlist.
The Zivo Bioscience stock analysis report makes it easy to digest most publicly released information about Zivo Bioscience and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Zivo Bioscience Stock analysis module also helps to analyze the Zivo Bioscience price relationship with some important fundamental indicators such as market cap and management efficiency.

Zivo Bioscience Stock Analysis Notes

About 34.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.02. Zivo Bioscience had not issued any dividends in recent years. The entity had a split on the 28th of May 2021. ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan. Zivo Bioscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10 people. For more information please call Andrew Dahl at 248 452 9866 or visit https://www.zivobioscience.com.

Zivo Bioscience Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Zivo Bioscience's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Zivo Bioscience or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Zivo Bioscience generated a negative expected return over the last 90 days
Zivo Bioscience has high historical volatility and very poor performance
Zivo Bioscience has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 20 K. Net Loss for the year was (8.97 M) with profit before overhead, payroll, taxes, and interest of 20 K.
Zivo Bioscience currently holds about 6.6 M in cash with (8.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.7.
Roughly 34.0% of the company outstanding shares are owned by insiders
Latest headline from MacroaxisInsider: Purchase by Christopher Maggiore of 2000 shares of Zivo Bioscience

Zivo Bioscience Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Zivo Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zivo Bioscience backward and forwards among themselves. Zivo Bioscience's institutional investor refers to the entity that pools money to purchase Zivo Bioscience's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Geode Capital Management LlcCommon Shares310.6 K1.2 M
Vanguard Group IncCommon Shares96.5 K378 K
Corecap Advisors LlcCommon Shares26.2 K103 K
Blackrock IncCommon Shares17 K66 K
Wells Fargo CompanyCommon Shares11.7 K46 K
Verdence Capital Advisors LlcCommon Shares10 K39 K
Ayrton Capital LlcWarrants48.9 K36 K
Pnc Financial Services Group IncCommon Shares1.3 KK
Note, although Zivo Bioscience's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Zivo Bioscience Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 28.54 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Zivo Bioscience's market, we take the total number of its shares issued and multiply it by Zivo Bioscience's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (134.87) % which means that it has lost $134.87 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (177.87) %, meaning that it created substantial loss on money invested by shareholders. Zivo Bioscience management efficiency ratios could be used to measure how well zivo bioscience manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 30th of September, Zivo Bioscience maintains the market risk adjusted performance of 0.8578, and Mean Deviation of 2.62. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Zivo Bioscience, as well as the relationship between them. Specifically, you can use this information to find out if the company will indeed mirror its model of past data patterns, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Zivo Bioscience, which can be compared to its rivals. Please check out Zivo Bioscience market risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Zivo Bioscience is priced fairly, providing market reflects its latest price of 2.8 per share. Please also validate Zivo Bioscience total risk alpha, which is currently at 0.0908 to confirm the company can sustain itself at a future point.

Zivo Bioscience Price Movement Analysis

The output start index for this execution was thirty with a total number of output elements of thirty-one. The Moving Average is predictive technique used to analyze Zivo Bioscience price data points by creating a series of averages of different subsets of Zivo Bioscience entire price series.

Zivo Bioscience Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zivo Bioscience insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zivo Bioscience's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zivo Bioscience insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Zivo Bioscience Predictive Daily Indicators

Zivo Bioscience intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Zivo Bioscience stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Zivo Bioscience Forecast Models

Zivo Bioscience time-series forecasting models is one of many Zivo Bioscience's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Zivo Bioscience's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Zivo Bioscience Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Zivo Bioscience prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Zivo Bioscience shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Zivo Bioscience. By using and applying Zivo Bioscience Stock analysis, traders can create a robust methodology for identifying Zivo Bioscience entry and exit points for their positions.
ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. ZIVO Bioscience, Inc. is based in Bloomfield Hills, Michigan. Zivo Bioscience operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 10 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Zivo Bioscience to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Options Analysis Now


Options Analysis

Analyze and evaluate options and option chains as a potential hedge for your portfolios
All  Next Launch Module
Check out Your Current Watchlist. You can also try Probability Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for analysis

When running Zivo Bioscience price analysis, check to measure Zivo Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zivo Bioscience is operating at the current time. Most of Zivo Bioscience's value examination focuses on studying past and present price action to predict the probability of Zivo Bioscience's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Zivo Bioscience's price. Additionally, you may evaluate how the addition of Zivo Bioscience to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Is Zivo Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zivo Bioscience. If investors know Zivo Bioscience will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zivo Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Zivo Bioscience is measured differently than its book value, which is the value of Zivo Bioscience that is recorded on the company's balance sheet. Investors also form their own opinion of Zivo Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Zivo Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zivo Bioscience's market value can be influenced by many factors that don't directly affect Zivo Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zivo Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine Zivo Bioscience value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zivo Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.